APA
Mokhtarani M., Diaz G. A., Rhead W., Berry S. A., Lichter-Konecki U., Feigenbaum A., Schulze A., Longo N., Bartley J., Berquist W., Gallagher R., Smith W., McCandless S. E., Harding C., Rockey D. C., Vierling J. M., Mantry P., Ghabril M., Brown R. S., Dickinson K., Moors T., Norris C., Coakley D., Milikien D. A., Nagamani S. C., Lemons C., Lee B. & Scharschmidt B. F. (20140616). Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. : Molecular genetics and metabolism.
Chicago
Mokhtarani M, Diaz G A, Rhead W, Berry S A, Lichter-Konecki U, Feigenbaum A, Schulze A, Longo N, Bartley J, Berquist W, Gallagher R, Smith W, McCandless S E, Harding C, Rockey D C, Vierling J M, Mantry P, Ghabril M, Brown R S, Dickinson K, Moors T, Norris C, Coakley D, Milikien D A, Nagamani S C, Lemons C, Lee B and Scharschmidt B F. 20140616. Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. : Molecular genetics and metabolism.
Harvard
Mokhtarani M., Diaz G. A., Rhead W., Berry S. A., Lichter-Konecki U., Feigenbaum A., Schulze A., Longo N., Bartley J., Berquist W., Gallagher R., Smith W., McCandless S. E., Harding C., Rockey D. C., Vierling J. M., Mantry P., Ghabril M., Brown R. S., Dickinson K., Moors T., Norris C., Coakley D., Milikien D. A., Nagamani S. C., Lemons C., Lee B. and Scharschmidt B. F. (20140616). Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. : Molecular genetics and metabolism.
MLA
Mokhtarani M, Diaz G A, Rhead W, Berry S A, Lichter-Konecki U, Feigenbaum A, Schulze A, Longo N, Bartley J, Berquist W, Gallagher R, Smith W, McCandless S E, Harding C, Rockey D C, Vierling J M, Mantry P, Ghabril M, Brown R S, Dickinson K, Moors T, Norris C, Coakley D, Milikien D A, Nagamani S C, Lemons C, Lee B and Scharschmidt B F. Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. : Molecular genetics and metabolism. 20140616.